In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ironwood Adds A China Wrinkle To Regional Deal Strategy

Executive Summary

The December US launch of linaclotide is a transformative event for Ironwood Pharmaceuticals, the GI drug’s discoverer. But the company’s recent deal with AstraZeneca to sell the drug in China represents another kind of feat and highlights the growing importance of regional deals to Western biotechs.


Related Content

Financings Of The Fortnight: Biotech Enthusiasm Is Beginning To Bubble
Biopharma Dealmaking Quarterly Statistics, Q4 2012
New Faces Top Tables In ‘Top Partners’ Survey Amidst Overall Decline
Genzyme’s Asian Expertise Drives Alnylam Co-Development Pact For TTR Candidates
New Irritable Bowel Disease And Burn Therapies Among Those Recommended By Europe’s CHMP
Biotech’s Declaration Of Independence And What Pharma Needs To Do About It
Strong Phase III Data Have Linaclotide On Track For Filing In 2011
Ironwood Pharmaceuticals: Independent for the Long Haul
Ironwood IPO Raises Plenty Of Cash And Plenty Of Questions For Biotech Investors
The Rise of Regional Dealmaking


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts